<span style="color: #222222;">India has become one of the frontrunners in the global effort to develop a vaccine for the containment of Covid-19 pandemic. Government agencies have stepped up collaboration with private partners to fastrack the approval process needed for development of a potential Covid vaccine. Bharat Biotech and Zydus Cadilla started the human clinical trials of their potential vaccines after getting the approvals from the Central Drug Standard Control Organization.</span><br />'' <span style="color: #222222;"> </span><br />'' <span style="color: #222222;">AIR correspondent reports that India has fast tracked its efforts for the development of Covid-19 vaccine which are under human clinical trials stage. India is considered a pharmacy of the world and 60 per cent of the vaccine at world level is supplied by India. ICMR and Bharat Biotech have joined hands for the development of a potential Covid-19 vaccine called 'Covaxin' whereas the Department of Biotechnology has partially funded the development of Zydus's vaccine ZyCov-D. Zydus has set the target to complete the phase-I and II human clinical trial in the next three months. However, the final outcome will depend on the cooperation of all clinical sites involved in this project.</span><br />'' <span style="color: #222222;"> </span><br />'' <span style="color: #222222;">Another top Indian pharma company Serum Institute of India has bagged a contract with British drugmaker AstraZeneca to supply one billion doses of Oxford University's potential COVID-19 vaccine. This vaccine is currently at the most advanced stage at the world level. The World Health Organization has expressed hope that the Covid vaccine will come by next year.</span><br />